Patient-derived organoids as a platform for modeling a patient’s response to chemoradiotherapy in esophageal cancer

3D patient-derived organoids (PDOs) have been utilized to evaluate potential therapies for patients with different cancers. However, the use of PDOs created from treatment-naive patient biopsies for prediction of clinical outcomes in patients with esophageal cancer has not yet been reported. Herein...

Descripción completa

Detalles Bibliográficos
Autores principales: Karakasheva, Tatiana A., Gabre, Joel T., Sachdeva, Uma M., Cruz-Acuña, Ricardo, Lin, Eric W., DeMarshall, Maureen, Falk, Gary W., Ginsberg, Gregory G., Yang, Zhaohai, Kim, Michele M., Diffenderfer, Eric S., Pitarresi, Jason R., Li, Jinyang, Muir, Amanda B., Hamilton, Kathryn E., Nakagawa, Hiroshi, Bass, Adam J., Rustgi, Anil K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556341/
https://www.ncbi.nlm.nih.gov/pubmed/34716381
http://dx.doi.org/10.1038/s41598-021-00706-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556341/
https://www.ncbi.nlm.nih.gov/pubmed/34716381
http://dx.doi.org/10.1038/s41598-021-00706-8

Ejemplares similares